← Back to Search

Other

Opioid-Free Pain Control for Orthopaedic Surgery Recovery (CORE Trial)

N/A
Waitlist Available
Led By Nady M Hamid, MD
Research Sponsored by OrthoCarolina Research Institute, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the safety and effectiveness of two different pain control strategies following routine orthopedic surgery. One group of patients will receive opioids for pain control, while the other group will receive a multimodal, opioid-free pain control strategy. Data will be collected on pain scores, overall comfort level, satisfaction with the surgical experience and recovery, constipation, falls, and overall satisfaction with pain control.

Who is the study for?
This trial is for adults needing certain orthopaedic surgeries, like spine or joint replacements, without a history of substance dependence, significant liver disease, renal insufficiency, GI bleeding/ulcers, or chronic opioid use. It excludes those on workers' comp., with alcohol dependence, taking strong anticoagulants (except aspirin), having outpatient procedures or revision surgeries.
What is being tested?
The study compares two pain management methods after routine orthopaedic surgery: one uses opioids and the other an opioid-free approach. Patient comfort, satisfaction with surgery and recovery, pain control effectiveness and side effects like constipation and falls will be measured.
What are the potential side effects?
Opioid-based protocols may lead to nausea, constipation, drowsiness or risk of addiction. The opioid-free method might include discomfort due to less familiar pain control techniques but aims to avoid these specific opioid-related side effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain
Secondary study objectives
General Health
Pain at 1 year postop
Pain at 12 hours postop
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: OpioidActive Control1 Intervention
The opioid-based arm utilizes traditional, standard-of-care treatment for each applicable surgery. The medications (including dosage and frequency) used in this arm vary depending on the surgery being performed; however, tend to include medications in the opioid family such as Hydromorphone, Hydrocodone, Tramadol, or Oxycodone.
Group II: Opioid-FreeActive Control1 Intervention
The opioid-free arm utilizes medications that do not belong to the opioid family of medications. All medications used are FDA-approved and no experimental medications are being used. The medications (including dosage and frequency) used in this arm vary depending on the surgery being performed; however, tend to include medications such as Gabapentin, Tylenol, Meloxicam, Bupivacaine, or Ketorolac.

Find a Location

Who is running the clinical trial?

OrthoCarolina Research Institute, Inc.Lead Sponsor
36 Previous Clinical Trials
5,535 Total Patients Enrolled
Nady M Hamid, MDPrincipal InvestigatorOrthoCarolina Research Institute, Inc.

Media Library

Opioid-Free (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04176783 — N/A
Pain Management Research Study Groups: Opioid, Opioid-Free
Pain Management Clinical Trial 2023: Opioid-Free Highlights & Side Effects. Trial Name: NCT04176783 — N/A
Opioid-Free (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04176783 — N/A
~66 spots leftby Dec 2025